ClinicalTrials.gg
Sign In

Retinal Neovascularization clinical trials

The registry lists 24 studies for Retinal Neovascularization across more than 10 countries. 2 are recruiting or about to start. 9 of them are mainly about Retinal Neovascularization (how this is decided). Per ClinicalTrials.gov, last updated 2026-09-22.

Get an email when these change. Save the Retinal Neovascularization studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
16
Status unknown
5
Recruiting
2
Terminated
1

Phase

Phase 2
9
Phase 3
4
Phase 4
3
Phase 1
2

Where

United States
5
Brazil
4
China
3
Switzerland
2
Iran, Islamic Republic of
2
Australia
2

Who runs them

University of Sao Paulo (3) · Notal Vision Inc. (2) · Xiamen Ophthalmology Center Affiliated to Xiamen University (2) · Insel Gruppe AG, University Hospital Bern (2) · Meyer Children's Hospital IRCCS (2) · National Eye Institute (NEI) (1) · Lions Eye Institute, Perth, Western Australia (1) · Shanghai Eye Disease Prevention and Treatment Center (1)

What is being tested here

Drugs under test in Retinal Neovascularization studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bevacizumab113
Curcumin111
Ranibizumab002
Propranolol002
Brolucizumab011
Squalamine lactate001
Squalamine001
Triamcinolone001
Aflibercept001

Drug classes tested here Angiogenesis inhibitors 1 open

Coming up

1phase 3 study under way
0studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

Who these studies take

Of the 2 Retinal Neovascularization studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
AgeWomenMen
100 (0%)0 (0%)
181 (50%)1 (50%)
301 (50%)1 (50%)
402 (100%)2 (100%)
502 (100%)2 (100%)
652 (100%)2 (100%)
752 (100%)2 (100%)
852 (100%)2 (100%)

Across all 24 studies, recruiting or not: 4% stop at 75 or younger and 4% at 65; 21% take children; 0% are for women only and 0% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 24 of 24. search them.